Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tenivac
- Development stage
- Approved
- Lead developer
- Sanofi Pasteur
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Tenivac is a vaccine indicated for active immunization for the prevention of tetanus and diphtheria in persons 7 years of age and older. Each 0.5 mL dose contains 5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid. The vaccine works by helping the body develop immunity to tetanus and diphtheria, which are serious bacterial diseases. Tetanus (lockjaw) causes painful muscle tightening that can lead to jaw locking, difficulty swallowing, and breathing problems. Diphtheria can cause breathing problems, paralysis, heart failure, or death. Tenivac is preservative-free and contains aluminum phosphate as an adjuvant.
- Brand names
- Tenivac
- Other names
- Tetanus and Diphtheria Toxoids Adsorbed
02
Targets
pMHC-II (Peptide-major histocompatibility complex class II complex)Tetanus and diphtheria toxoid-specific B-cell receptor
Beyond the preview
Go deeper on Tenivac.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tenivac.